F. Vertongen

2.4k total citations
53 papers, 1.9k citations indexed

About

F. Vertongen is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, F. Vertongen has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 11 papers in Hematology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in F. Vertongen's work include Hemoglobinopathies and Related Disorders (16 papers), Iron Metabolism and Disorders (8 papers) and Blood groups and transfusion (8 papers). F. Vertongen is often cited by papers focused on Hemoglobinopathies and Related Disorders (16 papers), Iron Metabolism and Disorders (8 papers) and Blood groups and transfusion (8 papers). F. Vertongen collaborates with scholars based in Belgium, France and Democratic Republic of the Congo. F. Vertongen's co-authors include Olivier Michel, R Sergysels, H. Collet, Johan Kips, Leo Robert, Jean Duchateau, Ruben Pauwels, Frédéric Cotton, Béatrice Gulbis and Léon Tshilolo and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

F. Vertongen

52 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Vertongen Belgium 20 544 435 402 380 364 53 1.9k
Jerry M. Bergstein United States 24 99 0.2× 99 0.2× 233 0.6× 104 0.3× 94 0.3× 64 1.8k
Jean Allen Canada 10 151 0.3× 121 0.3× 196 0.5× 147 0.4× 36 0.1× 15 1.4k
J F Moorhead United Kingdom 27 252 0.5× 106 0.2× 143 0.4× 433 1.1× 21 0.1× 94 2.7k
T. Lind United Kingdom 26 122 0.2× 281 0.6× 443 1.1× 392 1.0× 56 0.2× 66 2.0k
Jong Weon Choi South Korea 19 216 0.4× 181 0.4× 298 0.7× 111 0.3× 76 0.2× 76 1.1k
A. J. Bellingham United Kingdom 25 478 0.9× 687 1.6× 597 1.5× 72 0.2× 37 0.1× 79 1.8k
V. Matti Vehaskari United States 26 224 0.4× 93 0.2× 47 0.1× 198 0.5× 66 0.2× 55 2.6k
Moshe Berant Israel 24 150 0.3× 138 0.3× 239 0.6× 96 0.3× 38 0.1× 119 2.0k
Stephen A. Landaw United States 20 222 0.4× 666 1.5× 701 1.7× 33 0.1× 72 0.2× 57 1.8k
Jayanta Gupta United States 18 377 0.7× 41 0.1× 76 0.2× 174 0.5× 69 0.2× 27 1.9k

Countries citing papers authored by F. Vertongen

Since Specialization
Citations

This map shows the geographic impact of F. Vertongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Vertongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Vertongen more than expected).

Fields of papers citing papers by F. Vertongen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Vertongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Vertongen. The network helps show where F. Vertongen may publish in the future.

Co-authorship network of co-authors of F. Vertongen

This figure shows the co-authorship network connecting the top 25 collaborators of F. Vertongen. A scholar is included among the top collaborators of F. Vertongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Vertongen. F. Vertongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dupont, E., et al.. (2010). Multiple transfusions for sickle cell disease in the Democratic Republic of Congo: The importance of the hepatitis C virus. Transfusion Clinique et Biologique. 17(4). 254–259. 32 indexed citations
2.
Gulbis, Béatrice, Frédéric Cotton, A Ferster, et al.. (2008). Neonatal haemoglobinopathy screening in Belgium. Journal of Clinical Pathology. 62(1). 49–52. 45 indexed citations
3.
Tshilolo, Léon, Éléonore Kafando, Frédéric Cotton, et al.. (2008). Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: Lessons from pilot studies. Public Health. 122(9). 933–941. 90 indexed citations
4.
Kafando, Éléonore, Léon Savadogo, F. Vertongen, et al.. (2008). [Sickle cell disease: an anonymous survey of physicians in Burkina Faso].. PubMed. 68(3). 241–6. 2 indexed citations
5.
Ferster, Alina, Alain Kentos, C. M. Patricia Bradstreet, F. Vertongen, & Béatrice Gulbis. (2005). Drépanocytose : diagnostic et paramètres biologiques. Journal Européen des Urgences. 18(4). 228–229. 1 indexed citations
6.
Gulbis, Béatrice, Alina Ferster, Alain Kentos, et al.. (2005). [Sickle cell disease: exotic disease or a Belgian public health problem?].. PubMed. 26(4). S309–13. 2 indexed citations
7.
Gulbis, Béatrice, Frédéric Cotton, Alina Ferster, et al.. (2001). [Prevention of hemoglobinopathies in Brussels: a necessity?].. PubMed. 22(3). 133–40. 2 indexed citations
8.
Delange, François, Anne Van Onderbergen, Wael Shabana, et al.. (2000). Silent iodine prophylaxis in Western Europe only partly corrects iodine deficiency; the case of Belgium. European Journal of Endocrinology. 143(2). 189–196. 54 indexed citations
9.
Cotton, Frédéric, Chunqing Lin, Jasmine Parma, et al.. (2000). Hb Ube-2 [α68(E17)Asn→Asp] and Hb Hafnia [β116(G18)His→Gln] Observed During Neonatal Screening in Brussels. Hemoglobin. 24(1). 65–69. 2 indexed citations
10.
Cotton, Frédéric, Henri Wajcman, Vincent Hansen, et al.. (2000). HB Anderlecht [α20(BL)HIS→PRO]: A Silent Variant Found in a Congolese Newborn. Hemoglobin. 24(4). 299–304. 5 indexed citations
11.
Bürgi, H, Luc Portmann, J Podoba, F. Vertongen, & Miroslav Srbecký. (1999). Thyroid volumes and urinary iodine in Swiss school children, 17 years after improved prophylaxis of iodine deficiency. European Journal of Endocrinology. 140(1). 104–106. 33 indexed citations
12.
Delange, François, G. Benker, P. Caron, et al.. (1997). Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. European Journal of Endocrinology. 136(2). 180–187. 241 indexed citations
13.
14.
Michel, Olivier, Johan Kips, Jean Duchateau, et al.. (1996). Severity of Asthma Is Related to Endotoxin in House Dust. American Journal of Respiratory and Critical Care Medicine. 154(6). 1641–1646. 475 indexed citations
15.
Ferster, Alina, Francis Corazza, F. Vertongen, et al.. (1995). Transplanted sickle‐cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. British Journal of Haematology. 90(4). 804–808. 26 indexed citations
16.
Michel, Olivier, et al.. (1991). Domestic endotoxin exposure and clinical severity of asthma. Clinical & Experimental Allergy. 21(4). 441–448. 194 indexed citations
17.
Wajcman, Henri, et al.. (1989). HB Belliard [α56(E5)LYS→ASN] A New Fast-Moving α Chain Variant Found in a Subject of Spanish Origin. Hemoglobin. 13(2). 157–162. 6 indexed citations
18.
Peretz, Asaf, Jean Nève, F. Vertongen, J. P. Famaey, & L. Molle. (1987). Selenium status in relation to clinical variables and corticosteroid treatment in rheumatoid arthritis.. PubMed. 14(6). 1104–7. 30 indexed citations
19.
Poortmans, Jacques, et al.. (1986). Influence of the Degree of Metabolic Control on Physical Fitness in Type I Diabetic Adolescents. International Journal of Sports Medicine. 7(4). 232–235. 42 indexed citations
20.
Vanderpas, Jean & F. Vertongen. (1985). Erythrocyte vitamin E is oxidized at a lower peroxide concentration in neonates than in adults. Blood. 66(6). 1272–1277. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerry M. Bergstein Breakdown of academic impact, for papers by Jean Allen Breakdown of academic impact, for papers by J F Moorhead Breakdown of academic impact, for papers by T. Lind Breakdown of academic impact, for papers by Jong Weon Choi Breakdown of academic impact, for papers by A. J. Bellingham Breakdown of academic impact, for papers by V. Matti Vehaskari Breakdown of academic impact, for papers by Moshe Berant Breakdown of academic impact, for papers by Stephen A. Landaw Breakdown of academic impact, for papers by Jayanta Gupta
Rankless by CCL
2026